Loginova S Ia, Borisevich S V, Rusinov V L, Ulomskiĭ U N, Charushin V N, Chupakhin O N
Antibiot Khimioter. 2012;57(11-12):8-10.
The study of the toxicity of triazavirin, a new antiinfluenza agent, showed that the maximum concentration of the drug, inducing no microscopically visible changes in the structure of the monolayer and the cells of the MDCK and SKEV cell cultures, was 128 and 100 mcg/ml respectively. The maximum drug dose for single intraperitoneal administration inducing no signs of acute intoxication in albino mice weighing 10-12 g was 1000 mg/kg. In investigation of the chronic toxicity it was shown that oral administration of the drug (by 0.05 ml) to the albino mice in a dose of 200 mg/kg (maximum possible concentration by the solubility) daily for 10 days was well tolerated by the laboratory animals. The maximum tolerable dose of triazavirin for the albino mice was > or = 200 mg/kg.
新型抗流感药物三氮唑核苷的毒性研究表明,该药物在单层结构以及MDCK和SKEV细胞培养的细胞中未引起显微镜下可见变化的最大浓度分别为128微克/毫升和100微克/毫升。对体重10 - 12克的白化小鼠进行单次腹腔注射,未引发急性中毒迹象的最大药物剂量为1000毫克/千克。在慢性毒性研究中发现,对白化小鼠每日口服该药物(0.05毫升),剂量为200毫克/千克(根据溶解度得出的最大可能浓度),持续10天,实验动物耐受性良好。三氮唑核苷对白化小鼠的最大耐受剂量≥200毫克/千克。